1187594-13-3 Usage
General Description
The compound "2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile" is a highly complex chemical with numerous functional groups and elements. This molecule includes a pyrrolopyrimidine core, a functional group present in several biologically active molecules, it also contains a pyrazole ring and an azetidine ring. Moreover, it features an ethylsulfonyl group, a trimethylsilyl group, a nitrile group and an ether group. Other features include a silyl ether and an ethyl sulfone. Despite its complexity, very little appears to be known about the specific properties, chemistry, or potential applications of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 1187594-13-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,5,9 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1187594-13:
(9*1)+(8*1)+(7*8)+(6*7)+(5*5)+(4*9)+(3*4)+(2*1)+(1*3)=193
193 % 10 = 3
So 1187594-13-3 is a valid CAS Registry Number.
1187594-13-3Relevant articles and documents
AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
-
Paragraph 0125; 0126, (2018/08/29)
The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, infl
AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 58-60, (2009/09/28)
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
